Search Results - "McGee, Sharon"

miRNA Dysregulation in Breast Cancer by MULRANE, Laoighse, MCGEE, Sharon F, GALLAGHER, William M, O'CONNOR, Darran P

“…miRNAs have emerged, in the last decade, as key players in the carcinogenic process, with many candidates identified as playing important roles in many aspects…”
Get full text

Delivery of cancer care via an outpatient telephone support line: a cross-sectional study of oncology nursing perspectives on quality and challenges by Shah, Hely, Vandermeer, Lisa, MacDonald, Fiona, Larocque, Gail, Nelson, Shannon, Clemons, Mark, McGee, Sharon F.

“…Rationale Patient support lines (PSLs) assist in triaging clinical problems, addressing patient queries, and navigating a complex multi-disciplinary oncology…”
Get full text

Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective by McGee, Sharon F., Clemons, Mark, Savard, Marie-France

“…The advent of HER2-targeted therapies has led to an important shift in the management of HER2-positive early breast cancer. However, initial treatment…”
Get full text

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review by Ng, Terry L., Tu, Megan M., Ibrahim, Mohammed F. K., Basulaiman, Bassam, McGee, Sharon F., Srikanthan, Amirrtha, Fernandes, Ricardo, Vandermeer, Lisa, Stober, Carol, Sienkiewicz, Marta, Jeong, Ahwon, Saunders, Deanna, Awan, Arif A., Hutton, Brian, Clemons, Mark J.

“…Purpose Bone-modifying agents (BMAs) for bone metastases are commonly prescribed for many years even though randomized clinical trials are only 1–2 years in…”
Get full text

Pregnancy and neonatal outcomes following malignancy in pregnancy at a tertiary care Canadian center: a retrospective chart review by Saad, Mysa, Murphy, Malia S Q, McGee, Sharon F, El-Chaâr, Darine

“…Data on pregnancy-associated cancers (PACs) are lacking. The objectives of this study were to determine the incidence of PACs and describe the characteristics…”
Get more information

Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial by Petrovic, Bojana, Julian, Jim A, Liddy, Clare, Afkham, Amir, McGee, Sharon F, Morgan, Scott C, Segal, Roanne, Sussman, Jonathan, Pond, Gregory R, O'Brien, Mary Ann, Bender, Jacqueline L, Grunfeld, Eva

“…Cancer poses a significant global health burden. With advances in screening and treatment, there are now a growing number of cancer survivors with complex…”
Get full text

The Landscape of Breast Cancer Molecular and Histologic Subtypes in Canada by Wilkinson, Anna N, Ellison, Larry F, McGee, Sharon F, Billette, Jean-Michel, Seely, Jean M

“…To characterize the histologic and molecular subtype distribution of, and survival from, breast cancer (BC) among Canadian women overall, and by stage and age…”
Get full text

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey by Alzahrani, Mashari, Clemons, Mark, Sienkiewicz, Marta, Shrem, Noa Shani, McGee, Sharon F., Vandermeer, Lisa, Sehdev, Sandeep, Savard, Marie France, Awan, Arif, Canil, Christina, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Ng, Terry

“…Background Optimal use of bone-modifying agent (BMA) therapy in patients with bone metastases from breast and castrate-resistant prostate cancer (CRPC) is…”
Get full text

Vasomotor symptoms in early breast cancer—a “real world” exploration of the patient experience by Cole, Katherine Marie, Clemons, Mark, Alzahrani, Mashari, Liu, Michelle, Larocque, Gail, MacDonald, Fiona, Hutton, Brian, Piper, Ardelle, Fernandes, Ricardo, Pond, Gregory R., Vandermeer, Lisa, Emam, Khaled El, McGee, Sharon F.

“…Background Despite the frequency of vasomotor symptoms (VMS) in patients with early breast cancer (EBC), their optimal management remains unknown. A patient…”
Get full text

Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective by Bradbury, Michelle, Savard, Marie-France, Vandermeer, Lisa, Clemons, Lucas, Pond, Gregory, Hilton, John, Clemons, Mark, McGee, Sharon

“…Despite evidence from clinical trials showing the efficacy of shorter durations of therapy, most HER2-positive early breast cancer (EBC) patients receive a…”
Get full text

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer by McGee, Sharon F, Clemons, Mark, Pond, Gregory, Caudrelier, Jean-Michel, Liu, Michelle, Alzahrani, Mashari Jemaan, Ng, Terry L, Awan, Arif A, Sehdev, Sandeep, Hilton, John, Savard, Marie-France, Fallowfield, Lesley, Kumar, Vikaash, Freedman, Orit, Vandermeer, Lisa, Hutton, Brian, Bourque, Jean-Marc

“…Concerns exist regarding increased toxicities, including endocrine therapy toxicity, with concurrent radiation and endocrine therapy in early breast cancer…”
Get full text

miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro by MULRANE, Laoighse, MADDEN, Stephen F, GALLAGHER, William M, O'CONNOR, Darran P, BRENNAN, Donal J, GREMEL, Gabriela, MCGEE, Sharon F, MCNALLY, Sara, MARTIN, Finian, CROWN, John P, JIRSTRÖM, Karin, HIGGINS, Desmond G

“…Here, we describe an integrated bioinformatics, functional analysis, and translational pathology approach to identify novel miRNAs involved in breast cancer…”
Get full text

The impact of baseline Edmonton Symptom Assessment Scale scores on treatment and survival in patients with advanced non-small cell lung cancer by McGee, Sharon F., BSc, MD, PhD, Zhang, Tinghua, MSc, Jonker, Hannah, Laurie, Scott A., MD, Goss, Glen, MD, Nicholas, Garth, MD, Albaimani, Khalid, MD, Wheatley-Price, Paul, MD

“…Abstract Background & Objectives Palliative systemic therapy is frequently underutilsed in patients with advanced non-small cell lung cancer, for many reasons…”
Get full text

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas by MAGNUSSON, Kristina, DE WIT, Meike, WESTER, Kenneth, GRY, Marcus, BJARTELL, Anders, GALLAGHER, William M, REXHEPAJ, Elton, KILPINEN, Sami, KALLIONIEMI, Olli-Pekka, BELT, Eric, GOOS, Jeroen, MEIJER, Gerrit, BRENNAN, Donal J, BIRGISSON, Helgi, GLIMELIUS, Bengt, BORREBAECK, Carl A. K, NAVANI, Sanjay, UHLEN, Mathias, O'CONNOR, Darran P, JIRSTRÖM, Karin, PONTEN, Fredrik, JOHNSON, Louis B, MCGEE, Sharon F, LUNDBERG, Emma, NAICKER, Kirsha, KLINGER, Rut, KAMPF, Caroline, ASPLUND, Anna

“…The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated transcription factor and epigenetic regulator, was identified as a tissue…”
Get full text

Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study by Petrovic, Bojana, O'Brien, Mary Ann, Liddy, Clare, Afkham, Amir, McGee, Sharon F, Morgan, Scott C, Segal, Roanne, Bender, Jacqueline L, Sussman, Jonathan, Urquhart, Robin, Fitch, Margaret, Schneider, Nancy D, Grunfeld, Eva

“…Previous research has identified communication and care coordination problems for patients with cancer. Healthcare providers (HCPs) have reported communication…”
Get full text

A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer by Dent, Susan, Fergusson, Dean, Aseyev, Olexiy, Stober, Carol, Pond, Gregory, Awan, Arif A, McGee, Sharon F, Ng, Terry L, Simos, Demetrios, Vandermeer, Lisa, Saunders, Deanna, Hilton, John F, Hutton, Brian, Clemons, Mark

“…The optimal frequency for cardiac monitoring of left ventricular ejection fraction (LVEF) in patients receiving trastuzumab-based therapy for early breast…”
Get full text

Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists by Petrovic, Bojana, Bender, Jacqueline L, Liddy, Clare, Afkham, Amir, McGee, Sharon F, Morgan, Scott C, Segal, Roanne, O'Brien, Mary Ann, Julian, Jim A, Sussman, Jonathan, Urquhart, Robin, Fitch, Margaret, Schneider, Nancy D, Grunfeld, Eva

“…Healthcare providers have reported challenges with coordinating care for patients with cancer. Digital technology tools have brought new possibilities for…”
Get full text

JAM‐A expression positively correlates with poor prognosis in breast cancer patients by McSherry, Elaine A., McGee, Sharon F., Jirstrom, Karin, Doyle, Emma M., Brennan, Donal J., Landberg, Goran, Dervan, Peter A., Hopkins, Ann M., Gallagher, William M.

“…The cell–cell adhesion protein junctional adhesion molecule‐A (JAM‐A) influences epithelial cell morphology and migration. As migration is required for tumor…”
Get full text

Virtual follow‐up care among breast and prostate cancer patients during and beyond the COVID‐19 pandemic: Association with distress by Bender, Jacqueline L., Scruton, Sarah, Wong, Geoff, Abdelmutti, Nazek, Berlin, Alejandro, Easley, Julie, Liu, Zhihui Amy, McGee, Sharon, Rodin, Danielle, Sussman, Jonathan, Urquhart, Robin

“…Background The purpose of this study was to investigate associations between self‐reported distress (anxiety/depression) and satisfaction with and desire for…”
Get full text

microRNAs: a new class of breast cancer biomarkers by Mulrane, Laoighse, Klinger, Rut, McGee, Sharon F, Gallagher, William M, O'Connor, Darran P

“…MicroRNAs (miRNAs) are regulatory molecules known to be aberrantly expressed in cancer and contribute to numerous aspects of tumor biology including the…”
Get more information